Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol, betamethasone dipropionate, and calcipotriol + betamethasone topical treatment trial in mild psoriasis vulgaris
ChiCTR-TRC-12003543Phase 4Completed
- Sponsor
- Institute of Dermatology, Chinese Academy of Medical Sciences
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of calcipotriol, betamethasone dipropionate and calcipotriol + betamethasone in plaque psoriasis (3 arms), sponsored by Institute of Dermatology, Chinese Academy of Medical Sciences. Primary endpoint: PASI75. Started Jan 2011; status: completed.
02
Drugs
calcipotriolbetamethasone dipropionatecalcipotriol + betamethasone
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR-TRC-12003543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003543.